1. Home
  2. CASI vs INHD Comparison

CASI vs INHD Comparison

Compare CASI & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • INHD
  • Stock Information
  • Founded
  • CASI 1991
  • INHD 2019
  • Country
  • CASI China
  • INHD United States
  • Employees
  • CASI N/A
  • INHD N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • CASI Health Care
  • INHD
  • Exchange
  • CASI Nasdaq
  • INHD Nasdaq
  • Market Cap
  • CASI 20.5M
  • INHD 19.8M
  • IPO Year
  • CASI 1996
  • INHD 2023
  • Fundamental
  • Price
  • CASI $1.29
  • INHD $1.20
  • Analyst Decision
  • CASI Strong Buy
  • INHD
  • Analyst Count
  • CASI 1
  • INHD 0
  • Target Price
  • CASI $4.00
  • INHD N/A
  • AVG Volume (30 Days)
  • CASI 79.1K
  • INHD 312.9K
  • Earning Date
  • CASI 08-15-2025
  • INHD 07-28-2025
  • Dividend Yield
  • CASI N/A
  • INHD N/A
  • EPS Growth
  • CASI N/A
  • INHD N/A
  • EPS
  • CASI N/A
  • INHD N/A
  • Revenue
  • CASI $31,368,000.00
  • INHD $2,600,163.00
  • Revenue This Year
  • CASI N/A
  • INHD N/A
  • Revenue Next Year
  • CASI N/A
  • INHD N/A
  • P/E Ratio
  • CASI N/A
  • INHD N/A
  • Revenue Growth
  • CASI 8.39
  • INHD 656.40
  • 52 Week Low
  • CASI $1.09
  • INHD $1.11
  • 52 Week High
  • CASI $7.67
  • INHD $19.78
  • Technical
  • Relative Strength Index (RSI)
  • CASI 42.66
  • INHD 32.80
  • Support Level
  • CASI $1.21
  • INHD $1.15
  • Resistance Level
  • CASI $1.77
  • INHD $1.51
  • Average True Range (ATR)
  • CASI 0.13
  • INHD 0.09
  • MACD
  • CASI 0.01
  • INHD -0.00
  • Stochastic Oscillator
  • CASI 14.29
  • INHD 13.51

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: